The genes which lie behind AS have been amongst the highest priorities of researchers studying this disease around the world. The study suggests ERAP1 may be play a significant role in AS disease. This represents the most significant genetic discovery in AS since HLA-B27 was discovered in 1973. It is particularly gratifying that this is a distinctively Canadian achievement, with patients drawn from across Canada. SPARCC researchers have made genetic studies a priority as this will greatly advance knowledge about the cause of AS and has important implications for earlier diagnosis and development of more effective treatments.
https://sparcc.ca/wp-content/themes/osmosis/images/empty/thumbnail.jpg
150
150
SPARCC
SPARCC
https://sparcc.ca/wp-content/themes/osmosis/images/empty/thumbnail.jpg